|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Conservation,diversification and expansion of C2H2 zinc finger proteins in the Arabidopsis thaliana genome显示文摘 | CLAUDIA C E HEIKO S SIEGFRIED B | 2004 | BMC Genomic2004，5，： | 1 |
| 2 | Therapeutic potential of nitric oxide synthase gene manipulation显示文摘 | Von DL Victor JD | 2001 | Circulation2001，103，： | 1 |
| 3 | Janus mieelles显示文摘 | Rainer E Alexander B Heiko Z | 2001 | Macromolecules2001，34，4： | 1 |
| 4 | Comparison and classification of 3D objects surface point clouds on the example of feet显示文摘 | RAINER G BJORN E HEIKO S JOACHIM H | 2011 | Machine Vision and Applications2011，22，： | 1 |
| 5 | The distribution of realized stock volatility显示文摘 | Andersen T G Bollerslev T Diebold F X Heiko E | 2001 | Jour- nal of Financial Economies2001，61，1： | 1 |
| 6 | Therapeutic options for chronic myeloid leukemia: focus on imatinib ( Glivec, Gleevec^TM ) 显示文摘 | Martin Henkes Heiko van der Kuip Walter E Aulitzky | 2008 | Ther Clin Risk Manag2008，4，1： | 1 |
| 7 | Multimodality imaging using proton magnetic resonance spectroscopic imaging and ^(18)F-fluorodeoxyglucose-positron emission tomography in local prostate cancer显示文摘AIM To assess the relationship using multimodality imaging between intermediary citrate/choline metabolism as seen on proton magnetic resonance spectroscopic imaging(1H-MRSI) and glycolysis as observed on ^(18)F-fluorodeoxyglucose positron emission tomography/computed tomography(^(18)F-FDG-PET/CT) in prostate cancer(PCa) patients. METHODS The study included 22 patients with local PCa who were referred for endorectal magnetic resonance imaging/1HMRSI(April 2002 to July 2007) and ^(18)F-FDG-PET/CT and then underwent prostatectomy as primary or salvage treatment. Whole-mount step-section pathology was used as the standard of reference. We assessed the relationships between PET parameters [standardized uptake value(SUVmax and SUVmean)] and MRSI parameters [choline + creatine/citrate(CC/Cmax and CC/Cmean) and total number of suspicious voxels] using spearman's rank correlation, and the relationships of PET and 1H-MRSI index lesion parameters to surgical Gleason score.RESULTS Abnormal intermediary metabolism on 1H-MRSI was present in 21/22 patients, while abnormal glycolysis on ^(18)F-FDG-PET/CT was detected in only 3/22 patients. Specifically, index tumor localization rates were 0.95(95%CI: 0.77-1.00) for 1H-MRSI and 0.14(95%CI: 0.03-0.35) for ^(18)F-FDG-PET/CT. Spearman rank correlations indicated little relationship(ρ =-0.36-0.28) between 1H-MRSI parameters and ^(18)F-FDG-PET/CT parameters. Both the total number of suspicious voxels(ρ = 0.55, P = 0.0099) and the SUVmax(ρ = 0.46, P = 0.0366) correlated weakly with the Gleason score. No significant relationship was found between the CC/Cmax, CC/Cmean or SUVmean and the Gleason score(P = 0.15-0.79). CONCLUSION The concentration of intermediary metabolites detected by 1H MRSI and glycolytic flux measured ^(18)F-FDG PET show little correlation. Furthermore, only few tumors were FDG avid on PET, possibly because increased glycolysis represents a late and rather ominous event in the progression of PCa. | Amita Shukla-Dave Cecilia Wassberg Darko Pucar Heiko Schoder Debra A Goldman Yousef Mazaheri Victor E Reuter James Eastham Peter T Scardino Hedvig Hricak | 2017 | World Journal of Radiology2017，9，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员